Home > News > Biotech firms courting investors
November 5th, 2007
Biotech firms courting investors
Abstract:
Like another Cambridge biotech company, Alkermes Inc., Bind is trying to find better ways to deliver drugs - rather than trying to invent new drugs. Bind is focused on using nanotechnology to concentrate drugs in the areas affected by a disease, where they can be most effective. The company was cofounded by MIT professor Robert Langer and Harvard Medical School assistant professor Omid Farokhzad.
Source:
boston.com
Bookmark:
VC/Funding/Angel financing/Loans/Leases/Crowdsfunding
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013
INSCX™ exchange announces substantial increase in capital designated to provide Trade Finance for registered Nanomaterial Producers May 21st, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
Researchers Stitch Defects into the World’s Thinnest Semiconductor May 22nd, 2013
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Events/Classes
Precision Positioning Systems go Nano: New Miniaturized Piezo-Motor Driven Nanopositioning Stage by PI May 22nd, 2013
Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013
Xmark Media announces the 2013 Vacuum Expo & Vacuum Symposium, Ricoh Arena - Coventry 16-17 October May 21st, 2013
Iran to Hold 1st Conference on Applications of Nanotechnology in Energy Industry May 21st, 2013